Universal API Implementation Guide
1.1.20 - ci-build

Universal API Implementation Guide - Local Development build (v1.1.20) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Release 2024 Oct 29

Avastin and Cotellic - Questionnaire Updates

Type Available in QA (test) environment? Product(s) impacted linkId impacted (if applicable) OLD New
Update Yes Avastin avastin-fda-approved-indications where valueCoding.code = "hepatocellular-carcinoma"

Text: A type of liver cancer called hepatocellular carcinoma (HCC).

AVASTIN may be used with the medicine TECENTRIQ® (atezolizumab) when your liver cancer:

-has spread or cannot be removed by surgery, and you have not received other medicines by mouth or injection through your vein (IV) to treat your cancer.
where valueCoding.code = "hepatocellular-carcinoma"

Text: A type of liver cancer called hepatocellular carcinoma (HCC).

AVASTIN may be used with the medicine TECENTRIQ® (atezolizumab) or TECENTRIQ HYBREZA™ (atezolizumab and hyaluronidase-tqjs) when your liver cancer:

-has spread or cannot be removed by surgery, and
-you have not received other medicines by mouth or injection through your vein (IV) to treat your cancer.
Update Yes Cotellic cotellic-fda-approved-indications where valueCoding.code = "melanoma"

Text: COTELLIC is a prescription medicine that is used with the medicines ZELBORAF® (vemurafenib) and may be used with the medicine TECENTRIQ® (atezolizumab) to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery, and that has a certain type of abnormal "BRAF" gene.
where valueCoding.code = "melanoma"

Text: COTELLIC is a prescription medicine that is used with the medicines ZELBORAF® (vemurafenib) and may be used with the medicine TECENTRIQ® (atezolizumab) or TECENTRIQ HYBREZA™ (atezolizumab and hyaluronidase-tqjs) to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery, and that has a certain type of abnormal "BRAF" gene.